Acute cardiac care & resuscitation

Clinical Profile, Short and Long-Term Outcomes of Non-Ischaemic Cardiogenic Shock: A FRENSHOCK Sub-Analysis

ESC Heart FailPublished prospective registry

Authors' conclusion

In this large study, NICS accounted for almost two-thirds of all CS cases, with substantial rates of short- and long-term mortality. Future studies should evaluate interventions to improve early stratification and management. NCT02703038.

Study context

Population
Patients with non-ischaemic cardiogenic shock (NICS) in the FRENSHOCK registryNICS patients (63.7%) of 772 cardiogenic shock (CS) patients included
Participants
492 patients
Outcome
One-year mortality
Follow-up
1 year
Methodological details49 centers, sub-analysis
  • 49 centers
  • Sub-analysis

Main finding

As reported in the abstract

One-year mortality rate was

45.7% in the overall FRENSHOCK cohort

events

Independent factor: age (per year), aHR
1.03 [1.01-1.05], P < 0.01
Independent factor: chronic kidney disease (CKD), aHR
1.87 [1.25-2.80], P < 0.01
Independent factor: norepinephrine use, aHR
1.52 [1.02-2.26], P = 0.04
Independent factor: active cancer, aHR
1.91 [1.07-3.42], P = 0.03
Independent factor: acute renal replacement therapy, aHR
1.57 [1.01-2.46], P = 0.049

Observational data: associations, not effects.

Secondary outcomes

OutcomeValues
One-month mortalitySecondary outcomeNICS 25.6%
Composite of 1-year mortality, HTx, or VADSecondary outcomeNICS 53.9%

One-month mortality

Age, CKD and norepinephrine predictive; also associated with septic triggers

Composite of 1-year mortality, HTx, or ventricular assistance device (VAD)

Age, CKD and norepinephrine predictive; also associated with acute mechanical circulatory support, NYHA stage ≥ 3 and fluid administration

Original publication

Clinical Profile, Short and Long-Term Outcomes of Non-Ischaemic Cardiogenic Shock: A FRENSHOCK Sub-Analysis. ESC Heart Fail. Published 25 March 2025. doi:10.1002/ehf2.15046

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.